已收盤 08-07 16:00:00 美东时间
+1.530
+0.18%
Dolly Parton has officially entered the mega travel-stop business. Dolly's Tennessean Travel Stop opened last month on Interstate 65 about an hour south of Nashville and an hour north of Huntsville, A...
08-02 19:00
Costco Wholesale (COST) broke away from its familiar warehouse-and-gas combo model this summer after it opened the first standalone, fuel-only retail location in the company's history in Mission Viejo...
07-18 19:00
As Q2 2026 earnings season approaches, consumer staples stocks are drawing investor attention as markets assess demand for food, beverages, household products, tobacco, and other everyday consumer goo...
07-10 19:03
On CNBC’s “Mad Money Lightning Round,” Jim Cramer recommended buying Casey’s General Stores (NASDAQ:CASY), saying “buy 10 shares every three weeks.” Lending support to his choice, BMO Capital analyst Kelly Bania upgraded Casey’s from Market Perform to Outperform on June 29. When asked about Skyworks...
07-08 20:06
Massachusetts-based convenience store chain Cumberland Farms filed a registration statement with the U.S. Securities and Exchange Commission ahead of a potential initial public offering. The number of...
07-03 01:50
今日重点评级关注:Evercore ISI集团:维持ProQR Therapeutics"跑赢大市"评级,目标价从5美元升至6美元;摩根士丹利:维持霍尼韦尔"标配"评级,目标价从245美元升至490美元
06-30 10:14
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page. HC Wainwright & Co. analyst Arthur He upgraded Prime Medicine, Inc (NASDAQ:PRME) from Neutral to ...
06-29 20:42
BMO Capital analyst Kelly Bania upgrades Casey's General Stores (NASDAQ:CASY) from Market Perform to Outperform and maintains the price target from $950 to $950.
06-29 18:54
Supersized roadside retailer Buc-ee's is accelerating its U.S. expansion with plans for 15 new locations across the South, Southwest, and into the Midwest—encroaching on Casey's General Stores' (CASY)...
06-26 23:47
今日重点评级关注:Chardan Capital:维持Ocular Therapeutix"买入"评级,目标价从21美元升至23美元;Guggenheim:维持Amylyx Pharmaceuticals"买入"评级,目标价从30美元升至40美元
06-26 17:42